Quantcast

Latest Targeted therapy Stories

2014-12-23 23:00:38

RnRMarketResearch.com adds “Erbitux (Colorectal Cancer) – Forecast and Market Analysis to 2023” to its store.

2014-12-16 08:31:43

-- Novel irreversible pan-erbB inhibitor is active against patient-derived GBM xenografts overexpressing EGFR, including the disease-driving EGFRvIII mutation MENLO PARK, Calif., Dec.

2014-12-11 08:28:27

Studies Using Caris Molecular Intelligence(TM) Identify Standard as well as Novel Therapeutic Options Based on Molecular Characterization of Individual Patients' Tumors IRVING, Texas,

2014-11-19 12:28:49

LONDON and NEW YORK, November 19, 2014 /PRNewswire/ -- [[CENTER] ]http://www.abmrg.com/Global-Oncology-Market---Trends-Forecast-and-Pipeline-Analysis.html

Ovarian cancer cells
2014-11-19 03:00:37

An antibody therapy already in clinical trials to treat chronic lymphocytic leukemia (CLL) may also prove effective against ovarian cancer – and likely other cancers as well.

2014-11-17 08:31:41

Data from 13 accepted abstracts include: NORTH CHICAGO, Ill., Nov.

2014-11-14 16:25:22

- Data include results from a Phase 1 study of ABT-414 as monotherapy and in combination with radiation and/or chemotherapy in patients with newly diagnosed and recurrent/unresectable glioblastoma


Word of the Day
edulcoration
  • The act of sweetening by admixture of some saccharine substance.
The word 'edulcoration' comes from a Latin word meaning 'making sweet'.